NASDAQ:PETSPetmed Express Stock Price, Forecast & News

Petmed Express' stock was trading at $25.95 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PETS stock has increased by 23.9% and is now trading at $32.14.
View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Petmed Express.

Petmed Express is scheduled to release its next quarterly earnings announcement on Monday, October 19th 2020.
View our earnings forecast for Petmed Express.

Petmed Express Inc (NASDAQ:PETS) posted its quarterly earnings results on Monday, July, 20th. The company reported $0.39 earnings per share for the quarter, missing analysts' consensus estimates of $0.40 by $0.01. The business had revenue of $96.20 million for the quarter, compared to analyst estimates of $90.96 million. Petmed Express had a return on equity of 21.91% and a net margin of 9.41%. The firm's revenue was up 20.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.26 earnings per share.
View Petmed Express' earnings history.

Petmed Express declared a quarterly dividend on Monday, July 20th. Investors of record on Friday, July 31st will be given a dividend of $0.28 per share on Friday, August 7th. This represents a $1.12 dividend on an annualized basis and a yield of 3.48%. The ex-dividend date is Thursday, July 30th.
View Petmed Express' dividend history.

2 equities research analysts have issued 12 month price objectives for Petmed Express' stock. Their forecasts range from $20.00 to $31.00. On average, they anticipate Petmed Express' stock price to reach $25.50 in the next twelve months. This suggests that the stock has a possible downside of 20.7%.
View analysts' price targets for Petmed Express.

Headlines about PETS stock have been trending negative recently, according to InfoTrie. The research firm rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Petmed Express earned a news sentiment score of -2.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the immediate future.
View the latest news about Petmed Express.

Some companies that are related to Petmed Express include Amazon.com (AMZN), Netflix (NFLX), Booking (BKNG), Expedia Group (EXPE), Overstock.com (OSTK), Tripadvisor (TRIP), 1-800-Flowers.Com (FLWS), Shutterfly (SFLY), Groupon (GRPN) and U.S. Auto Parts Network (PRTS).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Petmed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Gilead Sciences (GILD), Alibaba Group (BABA), Cisco Systems (CSCO), Netflix (NFLX), Micron Technology (MU), Verizon Communications (VZ) and Advanced Micro Devices (AMD).

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

Petmed Express' stock is owned by many different institutional and retail investors. Top institutional investors include Prudential Financial Inc. (2.10%), Robeco Institutional Asset Management B.V. (1.74%), ProShare Advisors LLC (1.19%), WINTON GROUP Ltd (1.12%), Principal Financial Group Inc. (0.75%) and Raymond James Financial Services Advisors Inc. (0.65%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Robert C Schweitzer.
View institutional ownership trends for Petmed Express.

PETS stock was sold by a variety of institutional investors in the last quarter, including Hancock Whitney Corp, Cairn Investment Group Inc., North Star Investment Management Corp., Principal Financial Group Inc., Profit Investment Management LLC, Fisher Asset Management LLC, Wedge Capital Management L L P NC, and Alberta Investment Management Corp. Company insiders that have sold Petmed Express company stock in the last year include Bruce S Rosenbloom, Gian Fulgoni, and Menderes Akdag.
View insider buying and selling activity for Petmed Express.

PETS stock was bought by a variety of institutional investors in the last quarter, including Prudential Financial Inc., Robeco Institutional Asset Management B.V., ProShare Advisors LLC, Raymond James Financial Services Advisors Inc., Mackay Shields LLC, WINTON GROUP Ltd, Aigen Investment Management LP, and SG Americas Securities LLC.
View insider buying and selling activity for Petmed Express.

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PETS stock can currently be purchased for approximately $32.14.

Petmed Express has a market capitalization of $651.54 million and generates $284.13 million in revenue each year. Petmed Express employs 187 workers across the globe.

The official website for Petmed Express is www.1800petmeds.com.

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.